vs
GE医疗（CCRN）与MONRO, INC.（MNRO）财务数据对比。点击上方公司名可切换其他公司
MONRO, INC.的季度营收约是GE医疗的1.2倍（$293.4M vs $236.8M），MONRO, INC.净利率更高（3.8% vs -35.0%，领先38.8%），MONRO, INC.同比增速更快（-4.0% vs -23.6%），GE医疗自由现金流更多（$16.1M vs $9.1M），过去两年MONRO, INC.的营收复合增速更高（-2.7% vs -21.0%）
GE医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，品牌标识为GE HealthCare。公司主要业务分为四大板块：包含分子影像、CT、磁共振、妇科筛查及X光设备的医学影像业务、超声业务，以及聚焦远程患者监测、麻醉呼吸护理、心脏诊断、婴幼儿护理的患者护理解决方案业务，此外还开展医药相关业务。
蒙罗公司（Monro, Inc.）是一家汽车服务企业，创始并总部设在美国纽约州罗切斯特。截至2025年，蒙罗共拥有1260家门店，按门店数量与营收计算，是北美仅次于Driven Brands的第二大汽车服务企业。
CCRN vs MNRO — 直观对比
营收规模更大
MNRO
是对方的1.2倍
$236.8M
营收增速更快
MNRO
高出19.6%
-23.6%
净利率更高
MNRO
高出38.8%
-35.0%
自由现金流更多
CCRN
多$7.0M
$9.1M
两年增速更快
MNRO
近两年复合增速
-21.0%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $236.8M | $293.4M |
| 净利润 | $-82.9M | $11.1M |
| 毛利率 | — | 34.9% |
| 营业利润率 | -30.2% | 6.3% |
| 净利率 | -35.0% | 3.8% |
| 营收同比 | -23.6% | -4.0% |
| 净利润同比 | -2109.7% | 143.1% |
| 每股收益（稀释后） | $-2.56 | $0.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCRNMNRO
| Q4 25 | $236.8M | $293.4M | ||
| Q3 25 | $250.1M | $288.9M | ||
| Q2 25 | $274.1M | $301.0M | ||
| Q1 25 | $293.4M | $295.0M | ||
| Q4 24 | $309.9M | $305.8M | ||
| Q3 24 | $315.1M | $301.4M | ||
| Q2 24 | $339.8M | $293.2M | ||
| Q1 24 | $379.2M | $310.1M |
净利润CCRNMNRO
| Q4 25 | $-82.9M | $11.1M | ||
| Q3 25 | $-4.8M | $5.7M | ||
| Q2 25 | $-6.7M | $-8.1M | ||
| Q1 25 | $-490.0K | $-21.3M | ||
| Q4 24 | $-3.8M | $4.6M | ||
| Q3 24 | $2.6M | $5.6M | ||
| Q2 24 | $-16.1M | $5.9M | ||
| Q1 24 | $2.7M | $3.7M |
毛利率CCRNMNRO
| Q4 25 | — | 34.9% | ||
| Q3 25 | 20.4% | 35.7% | ||
| Q2 25 | 20.4% | 35.5% | ||
| Q1 25 | 20.0% | 33.0% | ||
| Q4 24 | — | 34.3% | ||
| Q3 24 | 20.4% | 35.3% | ||
| Q2 24 | 20.8% | 37.2% | ||
| Q1 24 | 20.4% | 35.5% |
营业利润率CCRNMNRO
| Q4 25 | -30.2% | 6.3% | ||
| Q3 25 | -2.4% | 4.4% | ||
| Q2 25 | -2.1% | -2.0% | ||
| Q1 25 | -0.3% | -8.1% | ||
| Q4 24 | -1.1% | 3.3% | ||
| Q3 24 | 0.9% | 4.4% | ||
| Q2 24 | -5.7% | 4.5% | ||
| Q1 24 | 0.8% | 3.3% |
净利率CCRNMNRO
| Q4 25 | -35.0% | 3.8% | ||
| Q3 25 | -1.9% | 2.0% | ||
| Q2 25 | -2.4% | -2.7% | ||
| Q1 25 | -0.2% | -7.2% | ||
| Q4 24 | -1.2% | 1.5% | ||
| Q3 24 | 0.8% | 1.9% | ||
| Q2 24 | -4.7% | 2.0% | ||
| Q1 24 | 0.7% | 1.2% |
每股收益（稀释后）CCRNMNRO
| Q4 25 | $-2.56 | $0.35 | ||
| Q3 25 | $-0.15 | $0.18 | ||
| Q2 25 | $-0.20 | $-0.28 | ||
| Q1 25 | $-0.02 | $-0.74 | ||
| Q4 24 | $-0.13 | $0.15 | ||
| Q3 24 | $0.08 | $0.18 | ||
| Q2 24 | $-0.47 | $0.19 | ||
| Q1 24 | $0.08 | $0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $108.7M | $4.9M |
| 总债务越低越好 | — | $45.0M |
| 股东权益账面价值 | $322.8M | $604.9M |
| 总资产 | $449.0M | $1.6B |
| 负债/权益比越低杠杆越低 | — | 0.07× |
8季度趋势，按日历期对齐
现金及短期投资CCRNMNRO
| Q4 25 | $108.7M | $4.9M | ||
| Q3 25 | $99.1M | $10.5M | ||
| Q2 25 | $81.2M | $7.8M | ||
| Q1 25 | $80.7M | $20.8M | ||
| Q4 24 | $81.6M | $10.2M | ||
| Q3 24 | $64.0M | $20.9M | ||
| Q2 24 | $69.6M | $18.7M | ||
| Q1 24 | $5.2M | $6.6M |
总债务CCRNMNRO
| Q4 25 | — | $45.0M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $71.5M | ||
| Q1 25 | — | $61.3M | ||
| Q4 24 | — | $59.3M | ||
| Q3 24 | — | $62.0M | ||
| Q2 24 | — | $112.0M | ||
| Q1 24 | — | $102.0M |
股东权益CCRNMNRO
| Q4 25 | $322.8M | $604.9M | ||
| Q3 25 | $408.1M | $601.7M | ||
| Q2 25 | $412.2M | $604.9M | ||
| Q1 25 | $418.2M | $620.8M | ||
| Q4 24 | $419.0M | $648.9M | ||
| Q3 24 | $424.7M | $651.9M | ||
| Q2 24 | $433.3M | $654.4M | ||
| Q1 24 | $462.4M | $656.8M |
总资产CCRNMNRO
| Q4 25 | $449.0M | $1.6B | ||
| Q3 25 | $538.2M | $1.6B | ||
| Q2 25 | $553.8M | $1.6B | ||
| Q1 25 | $576.2M | $1.6B | ||
| Q4 24 | $589.3M | $1.7B | ||
| Q3 24 | $597.4M | $1.7B | ||
| Q2 24 | $602.9M | $1.7B | ||
| Q1 24 | $648.4M | $1.7B |
负债/权益比CCRNMNRO
| Q4 25 | — | 0.07× | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | 0.12× | ||
| Q1 25 | — | 0.10× | ||
| Q4 24 | — | 0.09× | ||
| Q3 24 | — | 0.10× | ||
| Q2 24 | — | 0.17× | ||
| Q1 24 | — | 0.16× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.2M | $17.8M |
| 自由现金流经营现金流 - 资本支出 | $16.1M | $9.1M |
| 自由现金流率自由现金流/营收 | 6.8% | 3.1% |
| 资本支出强度资本支出/营收 | 0.9% | 3.0% |
| 现金转化率经营现金流/净利润 | — | 1.60× |
| 过去12个月自由现金流最近4个季度 | $40.1M | $49.6M |
8季度趋势，按日历期对齐
经营现金流CCRNMNRO
| Q4 25 | $18.2M | $17.8M | ||
| Q3 25 | $20.1M | $32.3M | ||
| Q2 25 | $4.2M | $-1.9M | ||
| Q1 25 | $5.7M | $28.9M | ||
| Q4 24 | $24.2M | $14.8M | ||
| Q3 24 | $7.5M | $62.6M | ||
| Q2 24 | $82.4M | $25.6M | ||
| Q1 24 | $6.0M | $-5.3M |
自由现金流CCRNMNRO
| Q4 25 | $16.1M | $9.1M | ||
| Q3 25 | $17.9M | $26.6M | ||
| Q2 25 | $2.3M | $-9.3M | ||
| Q1 25 | $3.8M | $23.2M | ||
| Q4 24 | $21.7M | $7.9M | ||
| Q3 24 | $6.3M | $57.6M | ||
| Q2 24 | $79.6M | $16.8M | ||
| Q1 24 | $3.8M | $-11.9M |
自由现金流率CCRNMNRO
| Q4 25 | 6.8% | 3.1% | ||
| Q3 25 | 7.2% | 9.2% | ||
| Q2 25 | 0.8% | -3.1% | ||
| Q1 25 | 1.3% | 7.9% | ||
| Q4 24 | 7.0% | 2.6% | ||
| Q3 24 | 2.0% | 19.1% | ||
| Q2 24 | 23.4% | 5.7% | ||
| Q1 24 | 1.0% | -3.8% |
资本支出强度CCRNMNRO
| Q4 25 | 0.9% | 3.0% | ||
| Q3 25 | 0.9% | 2.0% | ||
| Q2 25 | 0.7% | 2.5% | ||
| Q1 25 | 0.6% | 1.9% | ||
| Q4 24 | 0.8% | 2.2% | ||
| Q3 24 | 0.4% | 1.6% | ||
| Q2 24 | 0.8% | 3.0% | ||
| Q1 24 | 0.6% | 2.1% |
现金转化率CCRNMNRO
| Q4 25 | — | 1.60× | ||
| Q3 25 | — | 5.71× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.23× | ||
| Q3 24 | 2.92× | 11.08× | ||
| Q2 24 | — | 4.37× | ||
| Q1 24 | 2.23× | -1.42× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
MNRO
| Tires | $150.2M | 51% |
| Maintenance | $73.5M | 25% |
| Brakes | $35.1M | 12% |
| Steering | $24.9M | 8% |
| Batteries | $6.2M | 2% |
| Exhaust | $3.2M | 1% |
